Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Aurora Cannabis to Acquire Whistler Medical for $132 Million

Aurora CannabisAurora Cannabis to Acquire Whistler Medical for $132 Million Inc. (NYSE: ACB) announced this week that the company has entered into a letter of intent to acquire Whistler Medical Marijuana Corp. Whistler Medical will be acquired for up to $132 million in ACB shares.


The acquisition of Whistler Medical, a cannabis company that is widely renowned for its organic cannabis cultivation practices, will bring the number of independent companies who were first given access to produce organic cannabis from 8 to 1. Whistler Medical is one of the eight organic cannabis corporations who were given first approval and were then dubbed with “blessed eight”. The last independent member of the blessed eight after the acquisition is completed will be Delta 9 Cannabis.

Chief Corporate Officer of Aurora Cannabis, Cam Battley, stated in a phone interview: “I would call [Whistler] the crown jewel of organic cannabis production worldwide. It’s the first organic-certified company, and now we’ve essentially got the market to ourselves.”

The blessed eight companies had a significant amount of time to grow a diverse portfolio of cannabis genetics, while competitors couldn’t even begin the process. Chief Executive Officer of Robes Cannabis, Maxim Zavet, stated: “They have been able to plant their flag and build a reputation in the medical cannabis industry and industry as a whole.”

Curious about other great cannabis companies? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.


Aurora Cannabis to Acquire Whistler Medical for $132 Million

Cannin Investment Group: Your Hemp Stocks Experts is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020. 

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now. 

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp stocks